Ocean Biomedical, Inc. (NASDAQ: OCEA), a leading biopharma company that works to accelerate the development and commercialization of scientifically compelling…
Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted…